Lesions on the liver and pancreas most often result from benign growths, cysts, or localized infections, though cancers and inflammatory conditions also produce them. Imaging scans now pick up these spots so frequently that up to about a third of people over 40 will have an incidental liver lesion detected on a CT scan alone. The overwhelming majority turn out to be harmless, but the range of possible causes is wide enough that the word “lesion” on a radiology report can send anyone into a spiral. Understanding the different causes and how they behave makes a real difference in knowing what deserves worry and what does not.
How Most Liver and Pancreatic Lesions Get Found
The rise of high-resolution CT, MRI, and ultrasound over the past few decades means doctors are catching lesions that would have gone unnoticed a generation ago. Many of these are discovered incidentally, during a scan ordered for something completely unrelated. A scan for kidney stones, back pain, or a routine cancer screening can reveal a spot on the liver or a small cyst in the pancreas that was never causing symptoms. Radiologists have recognized that this “incidentaloma” problem creates its own risks: overdiagnosis of harmless findings can lead to unnecessary biopsies, anxiety, and expensive follow-up care that does more harm than the lesion itself.1Journal of the American College of Radiology. Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee
Pancreatic cysts are similarly common. Incidental pancreatic cystic lesions grow slowly, on the order of fractions of a millimeter per year on average, and only a small minority ever become cancerous. In one large retrospective analysis, only about 4 cases per 10,000 patient-years of follow-up developed pancreatic cancer.2PubMed. Incidental pancreatic cystic lesions: retrospective analysis of natural history and efficacy of imaging surveillance guidelines That does not mean they can be ignored, but it does mean the vast majority of incidentally found lesions in either organ will never need surgery.
Common Benign Liver Lesions
Three types of benign liver lesions account for the majority of incidental findings: hemangiomas, focal nodular hyperplasia, and hepatic adenomas. Each has a distinct cause and risk profile.
Hemangiomas are the most common benign liver tumor. They are tangles of blood vessels and are present from birth in many cases, though they can be detected at any age. On ultrasound, a typical hemangioma appears as a bright, well-defined mass usually under 3 centimeters, with very slow blood flow inside it.3PubMed Central. One stop shop approach for the diagnosis of liver hemangioma Most hemangiomas need no treatment and are only monitored if they grow large enough to cause discomfort.
Focal nodular hyperplasia, or FNH, is a solid mass of liver cells clustered around an abnormal central artery. It occurs across a broad age range and has no established link to oral contraceptive use. FNH is typically discovered incidentally and almost never becomes malignant. Hepatic adenomas, by contrast, are more clinically important. They occur primarily in women of childbearing age who have used oral contraceptives for an extended period; the longer the duration of use, the greater the risk.4PubMed. Hepatic adenoma and focal nodular hyperplasia Adenomas can also develop in people with certain glycogen storage diseases and in some people with insulin-dependent diabetes. Unlike hemangiomas and FNH, larger adenomas carry a small risk of bleeding or malignant transformation, which is why doctors sometimes recommend removing them.
Liver Abscesses
Liver abscesses are pockets of pus that form inside the organ, and they represent an infectious rather than neoplastic cause of liver lesions. The two main types are amoebic and pyogenic (bacterial). In regions where the parasite Entamoeba histolytica is common, amoebic liver abscess dominates. In one study from northern India, roughly 62% of liver abscesses were amoebic and about 25% were pyogenic.5PubMed Central. Profile of Amoebic vs Pyogenic Liver Abscess and Comparison of Demographical, Clinical, and Laboratory Profiles of these Patients From a Tertiary Care Center in Northern India Amoebic abscesses tend to appear as large, solitary collections in the right lobe of the liver and affect younger men who often have a history of alcohol use.
Pyogenic abscesses, on the other hand, are caused by bacteria. Escherichia coli is the most frequently isolated organism, followed by other gut bacteria like Klebsiella pneumoniae.6PubMed Central. Exploration of Various Diagnostic Modalities for Detection of Amoebic Liver Abscess and Co-Occurrence of Other Infective Aetiology, Eastern India Bacterial abscesses often arise when infection spreads from the biliary tract or from the gut via the portal vein. In Southern European settings, pyogenic abscesses were more common than amoebic ones, and amoebic cases were strongly associated with recent international travel or a migration history. In a European cohort, a history of migration or travel was the only factor independently associated with amoebic abscess after adjusting for other variables.7PubMed Central. Liver abscesses in Southern Europe: clinical and microbiological characterization of a retrospective cohort So geography and travel history play a large role in determining what kind of liver abscess a person develops.
Liver Cancer and Metastases
Malignant liver lesions fall into two broad categories: cancers that originate in the liver and cancers that spread to the liver from somewhere else. The two primary liver cancers are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (a cancer of the bile ducts within the liver). HCC is far more preventable: research has found that up to about 83% of HCC cases are attributable to modifiable risk factors like chronic hepatitis B or C infection, heavy alcohol use, obesity, and diabetes. For cholangiocarcinoma, only about 38% of cases are linked to modifiable risk factors, meaning a larger share arises without obvious preventable causes.8PubMed. Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
An emerging line of research has explored whether viral infections beyond hepatitis contribute to liver cancer risk. A study using a broad antibody screening technique found that a composite “viral score” reflecting exposure to many different viruses was associated with poorer liver function and predicted death in people with chronic liver disease, even after accounting for hepatitis status.9PubMed Central. Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma The evidence is still early-stage, but it suggests the relationship between viral exposure and liver cancer is broader than the hepatitis viruses alone.
The liver is also one of the most common sites for cancer to metastasize to from other organs. Its anatomy explains why. The liver receives a huge volume of blood through two separate pathways: the portal vein, which drains the entire gastrointestinal tract, and the hepatic artery, which carries blood from the general circulation. Cancers of the colon, stomach, and pancreas can seed the liver through the portal vein, while lung and breast cancers can reach it through the hepatic artery. The liver’s large size and its close physical contact with nearby organs like the stomach and pancreas also make it vulnerable to direct invasion by adjacent tumors.10PubMed Central. Liver Metastasis in Cancer: Molecular Mechanisms and Management In fact, liver metastases are far more common than primary liver cancers in Western countries.
Benign and Precancerous Pancreatic Lesions
The pancreas develops its own spectrum of lesions, many of which are cystic. Pancreatic pseudocysts are among the most straightforward. They are fluid-filled sacs that form after a bout of acute pancreatitis, when inflamed tissue walls off a collection of digestive enzymes and fluid. Unlike true cysts, they lack an epithelial lining. Pseudocysts are the most common complication of pancreatitis.11PubMed. Pancreatic pseudocyst after acute pancreatitis in children Many resolve on their own, though large or symptomatic ones sometimes need drainage.
More concerning are the cystic neoplasms of the pancreas, particularly intraductal papillary mucinous neoplasms (IPMNs). These are mucus-producing growths that develop in the pancreatic ducts. In a large study, about 91% of IPMNs arose from branch ducts (smaller side channels) rather than the main pancreatic duct, and the vast majority met criteria for low-risk features.12JAMA Network Open. Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous Neoplasms IPMNs matter because they sit on a spectrum from completely benign to potentially precancerous. Main-duct IPMNs carry a higher risk of progressing to cancer than branch-duct ones, which is why imaging surveillance protocols exist for people who have them.
Other cystic pancreatic neoplasms include serous cystadenomas, which are almost always benign, and mucinous cystic neoplasms, which carry some malignant potential and tend to occur in middle-aged women. The challenge with all of these is that they can look similar on imaging, and telling a harmless serous cyst from a mucinous one that warrants surgery is not always straightforward.
Pancreatic Cancer and Neuroendocrine Tumors
Pancreatic ductal adenocarcinoma (PDAC) is the most feared pancreatic lesion and one of the deadliest cancers overall. Most cases are driven by mutations in the KRAS gene, which is altered in the vast majority of PDACs and in their precursor lesions as well.13PubMed Central. Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models Risk factors include smoking, chronic pancreatitis, obesity, diabetes, and family history. The disease is difficult to detect early because the pancreas sits deep in the abdomen and early tumors rarely cause symptoms.
Pancreatic neuroendocrine tumors (PNETs) are a separate and less common category. They arise from hormone-producing cells in the pancreas and behave very differently from ductal adenocarcinoma. Some PNETs secrete hormones that cause dramatic symptoms, such as insulinomas that cause dangerously low blood sugar or gastrinomas that cause severe ulcers. Others are “nonfunctional” and produce no hormonal symptoms at all. Their behavior is unpredictable: higher tumor grade, spread to lymph nodes or the liver, and larger tumor size generally point to a worse outlook.14PubMed Central. Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment But some PNETs grow so slowly that they can be watched rather than operated on immediately.
Causes That Affect Both Organs
A few conditions produce lesions in the liver and pancreas simultaneously, which can be confusing on imaging and sometimes misleading clinically.
IgG4-related disease is an autoimmune condition in which the immune system causes inflammatory masses in various organs. When it targets the pancreas, it produces a form of autoimmune pancreatitis (type 1) that can look almost identical to pancreatic cancer on imaging: the pancreas swells, ducts narrow, and masses appear.15Medical Research Archives. Update on Epidemiology of IgG4-related Disease Involving the Liver and Pancreas IgG4-related disease can also cause inflammatory pseudotumors in the liver and thickening of the bile ducts. Distinguishing it from cancer matters enormously because IgG4-related disease responds to steroid treatment, while cancer obviously requires a completely different approach. Elevated serum IgG4 levels and biopsy findings usually settle the diagnosis, but the mimicry catches clinicians off guard regularly enough that it remains a well-known diagnostic trap.
Hereditary syndromes can also cause lesions in both organs. Von Hippel-Lindau disease, a genetic condition caused by mutations in the VHL gene, predisposes people to tumors in multiple organs. Pancreatic neuroendocrine tumors and pancreatic cysts are common findings. Multiple endocrine neoplasia type 1 (MEN1) similarly causes pancreatic neuroendocrine tumors, sometimes multiple ones. Both syndromes can involve the liver as well, whether through direct tumor development or through metastasis.16PubMed Central. Von Hippel-Lindau is Associated to Pancreatic Neuroendocrine Tumors: A Comprehensive Review
Parasitic infections are another shared cause, though rare outside endemic areas. Hydatid disease, caused by the tapeworm Echinococcus granulosus, most commonly involves the liver but occasionally affects the pancreas. Pancreatic hydatid cysts are very uncommon even where the parasite is widespread, with reported rates between 0.14% and 0.2% of all hydatid disease cases.17PubMed Central. Pancreatic echinococcosis When a hydatid cyst does form in the pancreas, it can trigger acute pancreatitis and be mistaken for a cystic tumor.18PubMed Central. Hydatid cyst of the pancreas revealed by acute pancreatitis: A case report Liver hydatid cysts, by contrast, are a routine diagnostic consideration in endemic regions of the Middle East, North Africa, and parts of South America.
When Fat Mimics a Lesion
Not every spot on an imaging scan represents a true growth. Fatty liver disease, which is extremely common, usually causes the liver to accumulate fat uniformly. But sometimes the fat deposits are patchy, creating focal areas of different density that can look like tumors on ultrasound or CT. These “pseudolesions” are not growths at all. They are simply uneven distributions of fat within the liver tissue. An MRI with specific fat-suppression sequences can usually resolve the question, but before that test is done, a patient may understandably be alarmed by a report mentioning multiple liver nodules.19PubMed Central. Multifocal nodular lesions in fatty liver mimicking neoplastic disease: a case report Nodular regenerative hyperplasia is another condition that produces multiple small nodules in the liver without being cancerous. It results from altered blood flow within the liver and is associated with certain medications, autoimmune diseases, and blood disorders.20Pathology – Research and Practice. Nodular regenerative hyperplasia – An under-recognized vascular disorder of liver
How Doctors Tell Lesions Apart
The diagnostic workup for a liver or pancreatic lesion depends on what the initial scan shows. For liver lesions, contrast-enhanced MRI is the workhorse: different types of lesions take up and wash out contrast dye in characteristic patterns. Hemangiomas, for instance, fill slowly from the edges inward, a pattern so distinctive that it often makes biopsy unnecessary. HCC has its own signature pattern of rapid contrast uptake followed by quick washout.
For pancreatic cystic lesions, both MRI and endoscopic ultrasound (EUS) perform well. Head-to-head comparisons have found that MRI and EUS are similarly accurate at classifying lesions as cystic or solid, with accuracy in the range of 88% to 98%.21PubMed. Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions Neither was clearly superior for detecting internal features like septa, mural nodules, or connection to the main pancreatic duct. For distinguishing benign from malignant pancreatic cysts, both MRI and EUS have similar discriminative ability as well.22European Journal of Radiology. Diagnostic performance of MRI and EUS in the differentiation of benign from malignant pancreatic cyst and cyst communication with the main duct EUS has the added advantage of allowing fine-needle aspiration during the same procedure, so fluid from a pancreatic cyst can be analyzed for markers that help determine whether it is mucinous or potentially malignant.
The Surveillance Disagreement
Once a pancreatic cyst is found and judged to be low risk, the question becomes how long and how aggressively to monitor it. This is where clinical guidelines diverge in a way that can be confusing for patients. More than five different professional organizations have published recommendations, and because no high-quality randomized trial data exist to guide the decision, every set of guidelines relies on retrospective data shaped by the kinds of patients each group typically sees.23Gastroenterology. Pancreatic Cyst Disease: A Review
Surgical organizations tend to recommend earlier intervention because their patient pools are skewed toward higher-risk referrals; gastroenterology groups, who see the large volume of tiny, incidentally found cysts, lean more toward watchful waiting and even stopping surveillance in low-risk cases. Neither approach is wrong. They reflect different trade-offs between the small risk of missing a cancer and the real costs of over-monitoring. A retrospective analysis found that existing guideline thresholds for “significant growth” overlap with the natural growth rate of harmless cysts, which averaged about a third of a millimeter per year. Malignancy was not associated with growth rate but was strongly associated with the presence of high-risk features like solid nodules within the cyst.2PubMed. Incidental pancreatic cystic lesions: retrospective analysis of natural history and efficacy of imaging surveillance guidelines For patients, the practical takeaway is that a slowly growing pancreatic cyst without concerning internal features is usually not an emergency, even if it triggers a guideline-recommended follow-up scan.
Metabolic Fingerprints of Liver Cancer
A newer area of research is whether blood-based metabolic profiles can distinguish people who will develop liver cancer from those who will not, potentially catching the disease before imaging can. A large population-based study across twelve cohorts found distinct metabolic signatures in people who later developed HCC versus cholangiocarcinoma. People who went on to develop HCC showed disrupted patterns in amino acid metabolism and bile acid production, while those who developed cholangiocarcinoma had different changes involving branched-chain amino acid pathways.24PubMed. Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohorts These findings are not yet used in routine screening, but they reinforce the idea that HCC and cholangiocarcinoma are biologically distinct diseases with different underlying metabolic disruptions, not just two versions of “liver cancer.” If validated, metabolic blood tests could eventually complement imaging in high-risk populations, catching early-stage cancers that a scan might miss or that have not yet formed a visible lesion.